首页> 外文期刊>Experimental and therapeutic medicine >MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2
【24h】

MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2

机译:MicroRNA-598通过直接靶向ZEB2抑制非小细胞肺癌细胞的增殖和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

An increasing number of studies have observed that microRNAs (miRNAs) are abnormally expressed in non-small cell lung cancer (NSCLC), and that their aberrant expression links with the progression and development of NSCLC. Therefore, it is necessary to full elucidate the specific roles of miRNAs in NSCLC, as this may facilitate the identification of novel therapeutic targets. In the present study, it was observed that miRNA-598 (miR-598) expression was significantly downregulated in NSCLC tissues and cell lines. Decreased miR-598 was negatively correlated with TNM stage and lymph node metastasis in NSCLC patients. In addition, ectopic expression of miR-598 reduced NSCLC cell proliferation and invasion in vitro. The zinc finger E-box-binding homeobox 2 (ZEB2) was validated as a direct target of miR-598 in NSCLC cells. ZEB2 was upregulated in NSCLC tissues and the upregulation of ZEB2 was inversely correlated with the miR-598 level. The results revealed that restored ZEB2 expression abrogated the inhibitory effects of miR-598 overexpression in NSCLC cells. In conclusion, the results of the present study revealed that miR-598 may inhibit the progression of NSCLC by directly targeting ZEB2, which suggests that this miRNA may be identified as a potential novel prognostic biomarker and therapeutic target for patients with NSCLC.
机译:越来越多的研究已经观察到微小RNA(miRNA)在非小细胞肺癌(NSCLC)中异常表达,并且它们的异常表达与NSCLC的进展和发育。因此,必须完全阐明MiRNA在NSCLC中的特定作用,因为这可以促进新的治疗靶标的鉴定。在本研究中,观察到MiRNA-598(miR-598)表达在NMSCLC组织和细胞系中显着下调。 MIR-598减少与NSCLC患者的TNM阶段和淋巴结转移呈负相关。此外,MIR-598的异位表达减少了NSCLC细胞增殖和体外侵袭。锌指E盒结合的Homeobox 2(Zeb2)被验证为NSCLC细胞中miR-598的直接靶标。在NSCLC组织中上调Zeb2,Zeb2的上调与miR-598水平相反。结果表明,恢复的Zeb2表达废除了MiR-598过表达在NSCLC细胞中的抑制作用。总之,本研究的结果表明,MIR-598可以通过直接靶向ZEB2来抑制NSCLC的进展,这表明该miRNA可以被鉴定为NSCLC患者的潜在新型预后生物标志物和治疗靶标。

著录项

  • 来源
  • 作者单位

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Liaoyang City Cent Hosp Dept Thorac Surg Shenyang 111000 Liaoning Peoples R China;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

    Peoples Hosp Liaoning Prov Dept Thorac Surg 33 Wenyi Rd Shenyang 110016 Liaoning Peoples R;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

    non-small cell lung cancer; microRNA-598; proliferation; invasion; zinc finger E-box-binding homeobox 2;

    机译:非小细胞肺癌;microRNA-598;增殖;入侵;锌手指E-BOX结合Homeobox 2;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号